Literature DB >> 17136959

Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999.

Douglas W Mapel1, David Dedrick, Kourtney Davis.   

Abstract

Persons with Chronic Obstructive Pulmonary Disease (COPD) are at risk for developing other smoking-related complications, including cardiac and vascular diseases. Information about the prevalence and incidence of these conditions is needed to anticipate their occurrence in clinical research. We conducted a cohort study using longitudinal administrative data to describe the prevalence and incidence of cardiovascular (CV) diseases among COPD patients treated by the Veterans Administration Medical System. The COPD cohort included all persons with a diagnosis of COPD admitted to a Veterans Administration Medical System hospital (N = 70,679) or seen in a outpatient clinic (N = 314,209) in fiscal year 1998. Each COPD patient was matched to a Veteran of the same age and gender who did not have a COPD diagnosis, creating a non-COPD cohort for comparison. Among all hospitalized Veterans, the prevalence of COPD steadily increased from 1991 to 1999, although the total number of Veterans hospitalized during this time period decreased by more than one-third. Among COPD patients hospitalized in 1998, the prevalence of coronary artery disease, congestive heart failure, and atrial fibrillation were very high (33.6%, 24.4%, and 14.3%, respectively) and significantly higher than those seen among the matched non-COPD cohort (27.1%, 13.5%, and 10.4%; p < 0.001). Among COPD outpatients, increased complications were found in every CV disease category with rate ratios that were greater than observed among inpatients. We conclude that CV diseases are remarkably prevalent among Veterans with COPD, and their incidence is likely to increase as the Veteran population ages.

Entities:  

Mesh:

Year:  2005        PMID: 17136959     DOI: 10.1081/copd-200050671

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  40 in total

1.  Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.

Authors:  Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2018-02

Review 2.  [Comorbidities of COPD].

Authors:  H Watz; H Magnussen
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

3.  Molecular multitasking in the airspace: alpha1-antitrypsin takes on thrombin and plasmin.

Authors:  Rubin M Tuder; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2007-05-31       Impact factor: 6.914

4.  Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study).

Authors:  Harjit Chahal; Susan R Heckbert; R Graham Barr; David A Bluemke; Aditya Jain; Mohammadali Habibi; Alvaro Alonso; Richard Kronmal; David R Jacobs; Joao A C Lima; Karol E Watson; Kiang Liu; Lewis J Smith; Philip Greenland
Journal:  Am J Cardiol       Date:  2015-03-24       Impact factor: 2.778

5.  Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.

Authors:  Jennifer Y So; Huaqing Zhao; Helen Voelker; Robert M Reed; Donald Sin; Nathaniel Marchetti; Gerard J Criner
Journal:  Ann Am Thorac Soc       Date:  2018-11

Review 6.  Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.

Authors:  Chad Wade; J Michael Wells
Journal:  Expert Rev Respir Med       Date:  2020-04-19       Impact factor: 3.772

Review 7.  The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease.

Authors:  Ayham Daher; Michael Dreher
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

8.  Assessment of arterial stiffness in chronic obstructive pulmonary disease by a novel method: cardio-ankle vascular index.

Authors:  A Ç Aykan; T Gökdeniz; F Boyacı; I Gül; E Hatem; E Kalaycıoğlu; T Turan; H Bektaş; M B Cilingir; D A Aykan; F Ayyıldız; S Altun
Journal:  Herz       Date:  2013-08-03       Impact factor: 1.443

Review 9.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

10.  Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population.

Authors:  Amir Sharafkhaneh; Nancy J Petersen; Hong-Jen Yu; Anand A Dalal; Michael L Johnson; Nicola A Hanania
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.